GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wuhan Easy Diagnosis Biomedicine Co Ltd (SZSE:002932) » Definitions » 5-Year Yield-on-Cost %

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) 5-Year Yield-on-Cost % : 1578.86 (As of May. 24, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Wuhan Easy Diagnosis Biomedicine Co 5-Year Yield-on-Cost %?

Wuhan Easy Diagnosis Biomedicine Co's yield on cost for the quarter that ended in Mar. 2024 was 1578.86.


The historical rank and industry rank for Wuhan Easy Diagnosis Biomedicine Co's 5-Year Yield-on-Cost % or its related term are showing as below:

SZSE:002932' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 7.35   Med: 162.46   Max: 1835.2
Current: 1578.86


During the past 13 years, Wuhan Easy Diagnosis Biomedicine Co's highest Yield on Cost was 1835.20. The lowest was 7.35. And the median was 162.46.


SZSE:002932's 5-Year Yield-on-Cost % is ranked better than
99.68% of 308 companies
in the Medical Devices & Instruments industry
Industry Median: 2.195 vs SZSE:002932: 1578.86

Competitive Comparison of Wuhan Easy Diagnosis Biomedicine Co's 5-Year Yield-on-Cost %

For the Medical Devices subindustry, Wuhan Easy Diagnosis Biomedicine Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuhan Easy Diagnosis Biomedicine Co's 5-Year Yield-on-Cost % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Wuhan Easy Diagnosis Biomedicine Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Wuhan Easy Diagnosis Biomedicine Co's 5-Year Yield-on-Cost % falls into.



Wuhan Easy Diagnosis Biomedicine Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Wuhan Easy Diagnosis Biomedicine Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Wuhan Easy Diagnosis Biomedicine Co  (SZSE:002932) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Wuhan Easy Diagnosis Biomedicine Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Wuhan Easy Diagnosis Biomedicine Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Dongxin Road, 2 Floor, Building E, International Students Pioneer Park, Guandong Science and Technology Park, Donghu Development Zone, Hubei, Wuhan, CHN, 430075
Wuhan Easy Diagnosis Biomedicine Co Ltd is engaged in the research and development, production and sales of in vitro diagnostic reagents and supporting instruments and mobile ECG products. The company's product profile consists of Molecular diagnosis, Chemiluminescence, Blood gas analysis, and others. It also provides various other solutions such as Mingde Biomolecular Diagnostic Service Solution, Mingde Biothoracic Center Solution, POCT Solution, Remote ECG network construction solution, and others.
Executives
Wang Rui Directors, executives
Wang Jian Fei Director

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Headlines

No Headlines